Download - Thyroid Carcinoma Presentation
![Page 1: Thyroid Carcinoma Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022051413/55262d0d4a7959da488b4f60/html5/thumbnails/1.jpg)
MOHD HELMY B ABU BAKARFARRAH HANNA BT MOHD NASIR
KHAIRUNISA BT JUHARI
![Page 2: Thyroid Carcinoma Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022051413/55262d0d4a7959da488b4f60/html5/thumbnails/2.jpg)
![Page 3: Thyroid Carcinoma Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022051413/55262d0d4a7959da488b4f60/html5/thumbnails/3.jpg)
Thyroid Malignancies Majority are primary tumors. Female > male (3:1).
![Page 4: Thyroid Carcinoma Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022051413/55262d0d4a7959da488b4f60/html5/thumbnails/4.jpg)
Typical Presentation of Thyroid Cancer
Painless lumpNormal thyroid function testsFound on routine examination or by the
patientSlow growth or no growth over several
months
![Page 5: Thyroid Carcinoma Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022051413/55262d0d4a7959da488b4f60/html5/thumbnails/5.jpg)
Signs & Symptoms of Malignant goitres:Patients are usually euthyroid.Thyroid nodule/ mass.Cervical nodes enlargement- local
discomfort in neck.Bone painCough- lung metastasisStridorDysphagiaHoarseness
![Page 6: Thyroid Carcinoma Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022051413/55262d0d4a7959da488b4f60/html5/thumbnails/6.jpg)
Risk factors for MalignancySolitary thyroid nodules in patients >60 or
<30 years of age Irradiation of the neck or face during infancy
or teenage yearsSymptoms of pain or pressure (especially a
change in voice)Male sexLarge Nodules (>3 or 4 cm)Growth of nodule
![Page 7: Thyroid Carcinoma Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022051413/55262d0d4a7959da488b4f60/html5/thumbnails/7.jpg)
Types of Thyroid Gland Malignancies1) Papillary : 60% Well-Differentiated
2) Follicular : 20%
3) Anaplastic : 5-8 % Poorly differentiated
4) Medullary : 5% Moderately differentiated
![Page 8: Thyroid Carcinoma Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022051413/55262d0d4a7959da488b4f60/html5/thumbnails/8.jpg)
Papillary Carcinoma
Most common form, esp in young adults.Assc. with previous exposure to ionizing
radiation.Slow growing, painless nodule & often
multifocal within the gland.TSH dependent.Non functional tumor.
![Page 9: Thyroid Carcinoma Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022051413/55262d0d4a7959da488b4f60/html5/thumbnails/9.jpg)
Spread:i) Lymphatic (early) - int jugular, para aortic,
jugulodigastric nodes.ii) Distant metastasis (rare) via blood –lungs,
bone, liver,etc.
Managements:- Total thyroidectomy + removal of involved
LN- Thyroxine: lifelong hormone replacement, to
suppress TSH secretion.
Prognosis: Excellent (10 yrs survival rate 85%)
![Page 10: Thyroid Carcinoma Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022051413/55262d0d4a7959da488b4f60/html5/thumbnails/10.jpg)
![Page 11: Thyroid Carcinoma Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022051413/55262d0d4a7959da488b4f60/html5/thumbnails/11.jpg)
Follicular CarcinomaOlder age gp, peak at 40-50 years old.Predisposition: Iodine-deficiency goitre.Slow growing, painless, solitary, cold
nodule.Spread: Hematogenous to lungs, bones,
liver.More aggressive than papillary ca.
![Page 12: Thyroid Carcinoma Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022051413/55262d0d4a7959da488b4f60/html5/thumbnails/12.jpg)
Managements:- Total thyroidectomy + preservation of
parathyroid gland.- Thyroxine replacement.- Radioactive iodine: for mets- Thyroglobulin estimation every 6 months-marker
of recurrence.
Prognosis in 10 yrs survival rate:- No mets: 90%
- Mets: 30%
![Page 13: Thyroid Carcinoma Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022051413/55262d0d4a7959da488b4f60/html5/thumbnails/13.jpg)
![Page 14: Thyroid Carcinoma Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022051413/55262d0d4a7959da488b4f60/html5/thumbnails/14.jpg)
Medullary CarcinomaNeuroendocrine neoplasm of
parafollicular cell (C cell)- secrete calcitonin,VIP, serotonin, etc.
Aetiology:1)Sporadic (80%): 40-50 yrs old.2)Assoc. with MEN IIa/IIb : 20-30 yrs old.
Others: Familial MTC, Von Hippel Lindau Syndrome, Neurofibromatosis
![Page 15: Thyroid Carcinoma Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022051413/55262d0d4a7959da488b4f60/html5/thumbnails/15.jpg)
Presentation:- Thyroid mass (hard enlargement).- Compression symptoms: dysphagia, hoarsness- Diarrhea : secretion of VIP
Spread: -Lymphatic: regional LN
-Hematogenous: lungs, liver, bones
![Page 16: Thyroid Carcinoma Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022051413/55262d0d4a7959da488b4f60/html5/thumbnails/16.jpg)
![Page 17: Thyroid Carcinoma Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022051413/55262d0d4a7959da488b4f60/html5/thumbnails/17.jpg)
Anaplastic CarcinomaRapidly growing,large and bulky, highly
malignant & metastasize widely.> elderly.Predisposition: endemic goitre.
Spread:1) Local invasion:- Recurrent laryngeal nerve: hoarseness- Trachea: dyspnoea,stridor- Esophagus: dysphagia- Cervical symphathetic nerves: Horner’s
syndrome.
![Page 18: Thyroid Carcinoma Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022051413/55262d0d4a7959da488b4f60/html5/thumbnails/18.jpg)
2) Lymphatic3) Hematogenous: lungs (common), etc.
Managements:- Resection rarely possible.- Mainly palliative to relieve pressure symptoms:
surgery debulking.
- Chemo/radiotherapy: not effective.
Prognosis: Fatal within 1 yr of diagnosis.
![Page 19: Thyroid Carcinoma Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022051413/55262d0d4a7959da488b4f60/html5/thumbnails/19.jpg)
![Page 20: Thyroid Carcinoma Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022051413/55262d0d4a7959da488b4f60/html5/thumbnails/20.jpg)
Managements:-Total thyroidectomy + removal of affected lymph
nodes.-Calcitonin level: monitor progress (any residual or
recurrence) and screen relatives (if inherited).- Inoperable tumor: Irradiation.- Prophylactic thyroidectomy for MEN IIa/IIb.
Prognosis: 30-50% for 10 yrs survival.
![Page 21: Thyroid Carcinoma Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022051413/55262d0d4a7959da488b4f60/html5/thumbnails/21.jpg)
TNM Staging Tumor (T) Stage
TX: Tumor cannot be evaluated. T0: There is no evidence of tumor. T1: Thyroid tumor is 2 centimeters (cm) or less. T2: Thyroid tumor is 2 cm to 4 cm, and within the thyroid. T3: The thyroid tumor is larger than 4 cm and within the thyroid, or any tumor that has
minimal extension outside of the thyroid. T4: The thyroid tumor has spread beyond the thyroid and involves other neighboring tissues
within the neck. All anaplastic thyroid cancers are considered T4 tumors. Tumors may be divided to T4a and T4b.
T4a: This refers to a thyroid tumor regardless of size, which extends beyond the capsule surrounding the thyroid gland invading the esophagus, trachea, and larynx .
T4b: The thyroid tumor invades blood vessels (the carotid artery or blood vessels in chest) and the covering around the vertebrae.
Note: All anaplastic thyroid cancers are considered T4 tumors, with T4a being surgically resectable and T4b being surgically unresectable.
Lymph Nodes (N) Stage NX: Nodes cannot be evaluated. N0: There are no cancer cells in the regional lymph nodes. N1: There are cancer cells in lymph nodes of the neck (cervical lymph nodes) or upper chest
(upper mediastinal lymph nodes). N1 nodes may be divided to N1a and N1b, depending on the distance from the thyroid.
Distant Metastasis (M) Stages MX: Presence of metastasis cannot be evaluated. M0: There is no distant metastasis. M1: There is distant metastasis, such as to distant lymph nodes, liver, lungs, and/or brain.
![Page 22: Thyroid Carcinoma Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022051413/55262d0d4a7959da488b4f60/html5/thumbnails/22.jpg)
Overall Stage Staging of follicular and papillary thyroid cancers also takes into account on the
age, since the disease has a higher mortality rate in people over the age of 45.
Staging for Follicular or Papillary Thyroid Cancer Stage I: T1, N0, M0 Stage II: T2, N0, M0 Stage III:
T3, N0, M0 T1-3, N1a, M0
Stage IV: T4a, N0-N1a, M0 T1-4a, N1, M0 T4b, any N, M0 T1-4, any N, M1
Staging for Medullary Thyroid Cancer Stage I: T1, N0, M0 Stage II: T2, N0, M0 Stage III: T1-3, N1a, M0 Stage IV: Any T, any N, M1
Staging for Anaplastic Thyroid Cancer
- All anaplastic thyroid cancers are considered to be Stage IV because of the aggressive, fast-growing nature of the disease. Stage IV is made up of any T, any N, and any M.
![Page 23: Thyroid Carcinoma Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022051413/55262d0d4a7959da488b4f60/html5/thumbnails/23.jpg)
InvestigationsBlood test:- Thyroid function test: TSH, T4, T3.- Calcitonin and serum calcium levels: if medullary
ca is suspected.
Ultrasound of thyroid gland.FNAC – for histological diagnosis.Thyroid scan (scintigraphy)- evaluate how
the cells in the nodule are functioning.Chest Xray- lung mets.Bone scan & radiographs – secondary
deposits.CT scan, MRI- staging.
![Page 24: Thyroid Carcinoma Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022051413/55262d0d4a7959da488b4f60/html5/thumbnails/24.jpg)
THANK YOU